FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084137 [Registered on: 04/04/2025] Trial Registered Prospectively
Last Modified On: 17/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Single Arm Study 
Public Title of Study   Observational Study about Antibiotic Susceptibility in General Intensive Care Unit 
Scientific Title of Study   The microorganism profile with antibiotic susceptibility in the crtitically ill patients in General Intensive Care Unit: A Prospective Observational Study 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sonia Negi 
Designation  Junior Resident 
Affiliation  IGMC ,Shimla 
Address  Department Of Anaesthesia, Indira Gandhi Medical College, Shimla
Department Of Anaesthesia, Indira Gandhi Medical College, Shimla
Shimla
HIMACHAL PRADESH
171009
India 
Phone  7262057727  
Fax    
Email  sonianegi001@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Usha Chaudhary 
Designation  Associate Professor 
Affiliation  Indira Gandhi Medical College 
Address  Department of Anaesthesia, Indira Gandhi Medical College, Shimla

Shimla
HIMACHAL PRADESH
171001
India 
Phone  9459301813  
Fax    
Email  Chaudhary.ushaarvind@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Usha Chaudhary 
Designation  Associate Professor 
Affiliation  Indira Gandhi Medical College 
Address  Department of Anaesthesia, Indira Gandhi Medical College, Shimla

Shimla
HIMACHAL PRADESH
171001
India 
Phone  9459301813  
Fax    
Email  Chaudhary.ushaarvind@gmail.com  
 
Source of Monetary or Material Support  
Indira Gandhi Medical College ,Shimla, Himachal Pradesh ,India , Pincode -171001 
 
Primary Sponsor  
Name  Indira Gandhi Medical College  
Address  Indira Gandhi Medical College, Lakkar Bazaar Road, Shimla, Himachal Pradesh, India , Pincode-171001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Usha Chaudhary  Indira Gandhi Medical College, Shimla  General Intensive Care Unit, Department of Anaesthesia,Indira Gandhi Medical College, Shimla
Shimla
HIMACHAL PRADESH 
9459301813

Chaudhary.ushaarvind@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, IGMC,Shimla  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B998||Other infectious disease,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  Adults with endotracheal tube in situ for more than 24 hrs or with tracheostomy tube for 5 to 15 days 
 
ExclusionCriteria 
Details  Patients admitted and intubated for more than 24 hours and then taken in GICU .
Patients on tracheostomy tube for more than 15 days. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To study the microorganism culture profile in GICU in blood , ETT or tracheostomy tube secretions,urine , blood and cvp tip culture.  The microorganism culture profile will be assessed in 2-3 days after the collection 
 
Secondary Outcome  
Outcome  TimePoints 
To study antibiotic susceptibility pattern of microorganism isolated.  One year after approval from ethical committee  
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   We will be taking culture specimens from different sites for example blood, urine, endotracheal tube secretions or tracheostomy tube secretions,cvp tip .Specimens will be collected from patients who will be admitted in GICU with endotracheal tube in situ within 24 hours of admission or inctubated in GICU itself or with tracheostomy tube in situ for 5 to 15 days.Samples will be sent and processed in department of microbiology in IGMC, Shimla for isolation of microorganisms and their antibiotic susceptibility and resistance will be done .Also correlation will be seen between empirical antibiotics and antibiotic sensitivity in culture report and correlation of microorganism profile between different cultures. 
Close